HAIFA, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ventures, today announced that the Company and its subsidiaries have received multiple awards recognizing excellence in innovation, scientific achievement, and industry leadership. Pluri was named Overall BioAgriculture Company of the Year by the Biotech Breakthrough Awards ...

Core Insights - Pluri Inc. has announced a collaboration with Instituto del Café de Chiapas to advance cell-based coffee manufacturing in Mexico, leveraging its subsidiary Coffeesai's technology [1][2][4] Group 1: Collaboration and Strategy - The collaboration aims to establish Chiapas as a hub for cell-based coffee innovation, combining biotechnology with local coffee traditions [2][4] - The partnership is structured around a three-phase roadmap to de-risk commercialization, starting with cell line development and moving towards pilot-scale biofarming and commercial-scale manufacturing [5][6] Group 2: Market Potential and Financial Outlook - The global coffee market exceeded $250 billion in 2024 and is projected to surpass $350 billion by 2030, indicating a significant opportunity for scalable production [5] - The collaboration is expected to create a revenue-generating model aligned with shareholder interests while transforming the future of coffee production [4][5] Group 3: Technological Innovation - Coffeesai will utilize Pluri's proprietary 3D cell expansion platform to develop sustainable coffee solutions that are resilient to climate change and market volatility [5][8] - The innovative process aims to eliminate the negative environmental impacts associated with traditional coffee farming, ensuring consistent quality and high yields [8]